Commonly used painkiller Ibuprofen may not be a safer alternative to antibiotics for women suffering from simple urinary tract infection, a study says.
Various studies have suggested that treatment with non-steroidal anti-inflammatory drugs such as Ibuprofen may support recovery of a urinary tract infection, raising the possibility that the use of antibiotics could be reduced.
However, the new study revealed that it is not safe to recommend Ibuprofen instead of antibiotics in uncomplicated cystitis, due to the increased risk of developing a serious upper urinary tract infection.
Using Ibuprofen could lead to longer duration of symptoms and more serious adverse events related to the spread of the primary infection.
"Initial treatment with Ibuprofen could reduce unnecessary use of antibiotics. However, until we can identify those women in need of antibiotic treatment to prevent complications, we cannot recommend Ibuprofen alone to women with uncomplicated UTIs," said researchers including Ingvild Vik from the University of Oslo in Norway.
For the study, detailed in the journal PLOS Medicine, the team randomised 383 women with uncomplicated urinary tract infections to receive either standard treatment of antibiotics for three days or Ibuprofen as a symptomatic treatment without an antimicrobial effect.
The results showed that women assigned to receive Ibuprofen without antibiotics took three days longer to get well on an average.
Further, among women in the Ibuprofen group, twelve (6.6 per cent) developed a febrile urinary tract infection, with a smaller proportion (3.9 per cent) developing a serious kidney infection which did not occur in the antibiotics group, the researchers noted.
--IANS
rt/mag/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
